LSV Asset Management decreased its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 30.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,300 shares of the company’s stock after selling 15,200 shares during the period. LSV Asset Management’s holdings in Pediatrix Medical Group were worth $450,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new position in shares of Pediatrix Medical Group during the fourth quarter worth approximately $3,066,000. Renaissance Technologies LLC lifted its holdings in Pediatrix Medical Group by 117.4% during the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock worth $11,005,000 after buying an additional 453,000 shares in the last quarter. Legal & General Group Plc boosted its position in Pediatrix Medical Group by 2.2% in the 4th quarter. Legal & General Group Plc now owns 238,935 shares of the company’s stock valued at $3,135,000 after buying an additional 5,033 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of Pediatrix Medical Group by 11.0% in the 4th quarter. Wells Fargo & Company MN now owns 66,028 shares of the company’s stock valued at $866,000 after buying an additional 6,521 shares during the period. Finally, Trexquant Investment LP raised its position in shares of Pediatrix Medical Group by 112.0% during the fourth quarter. Trexquant Investment LP now owns 431,230 shares of the company’s stock worth $5,658,000 after acquiring an additional 227,825 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.
Pediatrix Medical Group Stock Up 0.6 %
Shares of NYSE MD opened at $13.42 on Tuesday. The firm has a 50 day moving average price of $14.32 and a 200 day moving average price of $13.95. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The stock has a market cap of $1.15 billion, a P/E ratio of -11.18, a P/E/G ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on MD shares. Truist Financial lowered their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday. UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Macquarie began coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective on the stock. Finally, StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus price target of $16.75.
Get Our Latest Stock Report on Pediatrix Medical Group
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Recommended Stories
- Five stocks we like better than Pediatrix Medical Group
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- What is Forex and How Does it Work?
- 3 Hot New IPOs Defying the 2025 Market Slump
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.